It is a member of the apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like editing complex family together with APOBEC3B, which was found to be a source of mutagenesis in many major cancer types, including breast cancer [32]. This evidence concerns the gene APOBEC3B and breast carcinoma.